Diabetes, its treatment, and catastrophic medical spending in 35 developing countries

Diabetes Care

Volumn 35, Issue 2, 2012, Pages 319-326

  Smith Spangler, Crystal M ^a,b,c   Bhattacharya, Jay ^c   Goldhaber Fiebert, Jeremy D ^c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b Division of General Medical Disciplines   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; METFORMIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEVELOPING COUNTRY; DIABETES MELLITUS; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; SELF REPORT;

ADULT; DEVELOPING COUNTRIES; DIABETES MELLITUS; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84859077402     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1770     Document Type: Article

References (33)

1. Pauly MV, Zweifel P, Scheffler RM, Preker AS, Bassett M. Private health insurance indeveloping countries. Health Aff (Millwood) 2006;25:369-379 (Pubitemid 43529545)
2. Wagstaff A, Yu S. Do health sector reforms have their intended impacts? The World Bank's Health VIII project in Gansu province, China. J Health Econ 2007;26:505-535 (Pubitemid 46560146)
3. Wagstaff A. The economic consequences ofhealth shocks: evidence from Vietnam. J Health Econ 2007;26:82-100 (Pubitemid 44908723)
4. Goldhaber-Fiebert JD, Li H, Ratanawijitrasin S, et al. Inpatient treatment of diabetic patients in Asia: evidence from India, China, Thailand and Malaysia. Diabet Med 2010;27:101-108
5. Pepper DJ, Levitt NS, Cleary S, Burch VC. Hyperglycaemic emergency admissions toa secondary-level hospital: an unnecessary financial burden. S Afr Med J 2007;97:963-967 (Pubitemid 350027980)
6. Shobhana R, Rao PR, Lavanya A, Vijay V, Ramachandran A. Cost burden todiabetic patients with foot complications: a study from southern India. J Assoc Physicians India 2000;48:1147-1150
7. Newhouse JP. Free for All? Lessons From the Rand Health Insurance Experiment. Cambridge, MA, Harvard University Press, 1993
8. Danaei G, Finucane MM, Lu Y, et al.; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31-40
9. Ramachandran A, Ramachandran S, Snehalatha C, et al. Increasing expenditure onhealth care incurred by diabetic subjects in a developing country: a study from India. Diabetes Care 2007;30:252-256 (Pubitemid 46198327)
10. Codogno JS, Fernandes RA, Sarti FM, Freitas Júnior IF, Monteiro HL. The burden of physical activity on type 2 diabetes public healthcare expenditures among adults: a retrospective study. BMC Public Health 2011;11:275
11. Chale SS, Swai AB, Mujinja PG, McLarty DG. Must diabetes be afatal disease in Africa? Study of costs of treatment. BMJ 1992;304:1215-1218
12. Alwan AD, Galea G, Stuckler D. Development atrisk: addressing noncommunicable diseases at the United Nations high-level meeting. Bull World Health Organ 2011;89:546-546A
13. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-858 (Pubitemid 47362344)
14. Ustun T, Chatterji S, Mechbal A. The World Health Surveys. In Health Systems Performance Assessment: Debates, Methods, and Empiricism. Murray C, Evans D, Eds. Geneva, World Health Org., 2003
15. World Health Organization. World Health Survey: current status of the World Health Survey [article online], 2011. Available from http://www.who.int/ healthinfo/survey/en/index.html. Accessed 21 October 2009
16. The World Bank. How we classify countries [article online], 2011. Available from http://data.worldbank.org/about/country-classifications. Accessed 9 December 2011
17. World Bank World Development Indicators. WDI online: database [Internet], 2011 Available from http://ddp-ext.worldbank.org/ext/DDPQQ/member.do?method= getMembers&userid=1&queryId=6. Accessed 10 August 2011
18. Xu K, Evans DB, Carrin G, Aguilar-Rivera AM, Musgrove P, Evans T. Protecting households from catastrophic health spending. Health Aff (Millwood) 2007;26:972-983
19. World Health Organization. WHO model list of essential medicines: 12th List, April 2001 [article online], 2002. Available from http://apps.who.int/ medicinedocs/en/d/Jh3003e/3.html. Accessed 16 June 2011
20. El Fakiri F, Bruijnzeels MA, Hoes AW. No evidence for marked ethnic differences in accuracy of self-reported diabetes, hypertension, and hypercholesterolemia. J Clin Epidemiol 2007;60:1271-1279 (Pubitemid 350061140)
21. Goldman N, Lin IF, Weinstein M, Lin YH. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol 2003;56:148-154 (Pubitemid 36315941)
22. Wu SC, Li CY, Ke DS. The agreement between self-reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan. Public Health 2000;114:137-142 (Pubitemid 30206832)
23. Yu ST, Chang HY, Lin MC, Lin YH. Agreement between self-reported and health insurance claims on utilization of health care: a population study. J Clin Epidemiol 2009;62:1316-1322
24. Cook BL, Manning WG. Measuring racial/ethnic disparities across the distribution of health care expenditures. Health Serv Res 2009;44:1603-1621
25. Koenker R, Hallock KF. Quantile regression. J Econ Perspect 2001;15:143-156 (Pubitemid 33594780)
26. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-1757 (Pubitemid 43767064)
27. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 2006;368:1651-1659 (Pubitemid 46048553)
28. Miller G, Pinto D, Vera-Hernandez M. High-Powered Incentives in Developing Country Health Insurance: Evidence From Colombia's Regimen Subsidiado. Cambridge, MA, National Bureau of Economic Research, 2009. ([NBER working paper no. 15456])
29. Hornberger J, Shewade A, Gutierrez H. How are coverage decisions made in publicly funded healthcare programs in low- and middle-income countries? Abstract presented at the 16th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, 21-25 May 2011, at the Hilton Baltimore, Baltimore, Maryland.
30. Sadikot SM, Nigam A, Das S, et al. The burden of diabetes and impaired fasting glucose in India using the ADA 1997 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract 2004;66:293-300 (Pubitemid 39469375)
31. Lage A. Global pharmaceutical development and access: critical issues of ethics and equity. MEDICC Rev 2011;13:16-22
32. World Health Organization. Health systems financing: the path to universal coverage [article online], 2010. Available from http://www.who.int/ whr/2010/en/index.html. Accessed 27 October 2011
33. Yip W, Mahal A. The health care systems of China and India: performance and future challenges. Health Aff (Millwood) 2008;27:921-932